It is the internal testing website that you are visiting. Please go to our official customer website (www.myplaniq.com).
Find A Portfolio/Ticker
Comparison Box
PPH: VanEck Pharmaceutical ETF (ETF)
Basic Info 105.75 0.73(0.70%) June 05
| Asset Class: | Health |
| MyPlanIQ Rating: | (94%) |
| Start Date: | 02/01/2000 |
| Last Dividend Date: | 04/01/2026 |
| 12-Mo. Yield | 2.46% |
| Expenses | 0.36% |
| Sign up to get fund ranking change alerts | |
Performance Analytics (As of 06/03/2026)
Not up-to-date? Try| Last 1 Week* | YTD*(2026) | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Since 02/01/2000 |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return(%) | 1.0 | 3.3 | 22.3 | 13.6 | 10.2 | 8.1 | 9.8 | 8.7 | 6.1 | 22.0 | 8.0 | 7.0 | 2.6 | 17.8 | 5.5 | 19.4 | -5.9 | 15.2 | -17.8 | 3.5 | 23.2 | 36.7 | 13.1 | 16.8 | 1.9 | 18.1 | -19.7 | 5.8 | 15.8 | -1.8 | -6.3 | 9.6 | -23.3 | -12.6 | 30.8 |
| Sharpe Ratio | NA | 0.2 | 1.16 | 0.68 | 0.49 | 0.37 | NA | NA | 0.26 | 1.0 | 0.41 | 0.28 | 0.07 | 1.46 | 0.18 | 1.25 | -0.42 | 1.25 | -0.98 | 0.2 | 1.68 | 3.39 | 1.2 | 0.93 | 0.13 | 0.91 | -0.68 | 0.2 | 1.12 | -0.33 | -0.5 | 0.47 | -0.85 | -0.71 | 0.98 |
| Draw Down(%) | NA | 10.8 | 10.8 | 18.1 | 20.3 | 29.7 | NA | NA | 46.4 | 14.9 | 12.7 | 10.3 | 20.3 | 7.1 | 29.7 | 10.6 | 18.4 | 9.8 | 20.8 | 17.5 | 9.0 | 6.4 | 7.7 | 14.5 | 15.3 | 19.7 | 33.9 | 10.2 | 6.9 | 11.7 | 18.8 | 14.2 | 39.5 | 22.4 | 21.6 |
| Standard Deviation(%) | NA | 16.8 | 17.0 | 15.1 | 15.0 | 17.0 | NA | NA | 18.2 | 19.2 | 10.9 | 12.1 | 17.4 | 12.2 | 29.4 | 14.4 | 17.4 | 11.7 | 18.3 | 17.4 | 13.8 | 10.8 | 11.0 | 18.0 | 14.1 | 19.7 | 30.2 | 13.1 | 11.1 | 12.1 | 14.6 | 19.0 | 28.7 | 21.7 | 30.4 |
| Treynor Ratio | NA | 0.03 | 0.19 | 0.11 | 0.08 | 0.07 | NA | NA | 0.05 | 0.19 | 0.06 | 0.04 | 0.02 | 0.19 | 0.05 | 0.19 | -0.07 | 0.16 | -0.17 | 0.04 | 0.24 | 0.4 | 0.13 | 0.18 | 0.02 | 0.19 | -0.21 | 0.02 | 0.13 | -0.04 | -0.06 | 0.07 | -0.19 | -0.14 | 0.26 |
| Alpha | NA | 0.04 | 0.0 | 0.03 | 0.02 | 0.0 | NA | NA | -0.01 | 0.02 | 0.03 | 0.01 | 0.01 | 0.02 | -0.02 | -0.01 | -0.02 | 0.01 | -0.04 | -0.03 | -0.01 | -0.01 | -0.01 | 0.02 | -0.02 | 0.0 | -0.01 | 0.01 | 0.02 | -0.06 | -0.06 | -0.07 | -0.04 | -0.02 | -0.08 |
| Beta | NA | 0.97 | 1.05 | 0.92 | 0.87 | 0.94 | NA | NA | 1.0 | 1.0 | 0.75 | 0.85 | 0.77 | 0.94 | 1.02 | 0.95 | 1.0 | 0.91 | 1.04 | 0.98 | 0.97 | 0.92 | 1.0 | 0.94 | 1.0 | 0.95 | 0.97 | 1.07 | 0.95 | 1.04 | 1.12 | 1.21 | 1.3 | 1.11 | 1.17 |
| RSquared | NA | 0.76 | 0.8 | 0.74 | 0.75 | 0.8 | NA | NA | 0.75 | 0.8 | 0.64 | 0.69 | 0.79 | 0.74 | 0.92 | 0.79 | 0.84 | 0.59 | 0.84 | 0.89 | 0.84 | 0.79 | 0.82 | 0.89 | 0.84 | 0.78 | 0.85 | 0.78 | 0.63 | 0.54 | 0.6 | 0.79 | 0.83 | 0.62 | 0.47 |
| Yield(%) | N/A | 0.8 | 2.4 | 2.4 | 2.3 | 2.3 | 3.7 | 4.0 | N/A | 2.1 | 2.1 | 2.2 | 1.6 | 1.9 | 1.7 | 2.1 | 1.8 | 2.1 | 2.0 | 2.0 | 2.1 | 2.6 | 3.7 | 4.4 | 3.3 | 9.5 | 3.1 | 2.9 | 4.9 | 2.4 | 2.3 | 2.1 | 1.6 | 1.2 | 4.6 |
| Dividend Growth(%) | N/A | -54.0 | 26.7 | 39.7 | 50.1 | -3.6 | N/A | N/A | N/A | 7.4 | 0.5 | 41.3 | -3.8 | 13.2 | -2.8 | 5.1 | -5.2 | -10.5 | 0.9 | 15.2 | 5.7 | -24.7 | -3.4 | 30.0 | -62.8 | 140.8 | 9.9 | -35.4 | 96.8 | -6.6 | 18.7 | 2.7 | 11.6 | -66.9 | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 02/01/2000
Calculate Performance
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
|
View Historical Data in an advanced chart |
Use MyPlanIQ Comparison to compare with multiple funds or portfolios |
See Health Asset Class Trend Rankings |
Top Rated Funds in Health
Best Mutual Funds
- VGHCX (VANGUARD HEALTH CARE FUND INVESTOR SHARES) (97%)
- HGHAX (THE HARTFORD HEALTHCARE FUND CLASS A) (79%)
- FSMEX (MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO) (78%)
- FBIOX (BIOTECHNOLOGY PORTFOLIO BIOTECHNOLOGY PORTFOLIO) (77%)
- FBTIX (FIDELITY ADVISOR BIOTECHNOLOGY FUND CLASS I) (77%)
- FPHAX (PHARMACEUTICALS PORTFOLIO PHARMACEUTICALS PORTFOLIO) (75%)
- FSHCX (HEALTH CARE SERVICES PORTFOLIO HEALTH CARE SERVICES PORTFOLIO) (74%)
- FSPHX (HEALTH CARE PORTFOLIO HEALTH CARE PORTFOLIO) (74%)
- FHCIX (FIDELITY ADVISOR HEALTH CARE FUND CLASS I) (73%)
- SHSSX (BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO INSTITUTIONAL) (66%)
Best ETFs
- DRGS (RBS Global Big Pharma ETN) (100%)
- XLV (Health Care Select Sector SPDR Fund) (96%)
- BBH (VanEck Biotech ETF) (94%)
- IBB (iShares Biotechnology ETF) (94%)
- PPH (VanEck Pharmaceutical ETF) (94%)
- FBT (First Trust NYSE Arca Biotechnology Index Fund) (91%)
- FXH (First Trust Health Care AlphaDEX Fund) (90%)
- IHE (iShares U.S. Pharmaceuticals ETF) (88%)
- IHF (iShares U.S. Healthcare Providers ETF) (88%)
- IHI (iShares U.S. Medical Devices ETF) (88%)
Best Closed End Funds
- BME (BlackRock Health Sciences Trust) (100%)
- GRX (Gabelli Healthcare & WellnessRx Trust) (99%)
- HQH (Tekla Healthcare Investors) (98%)
- HQL (Tekla Life Sciences Investors) (98%)
